Objectives
The Application and Implementation of Medical Statistics (AIMS) Special Interest Group (SIG) objective is to support and contribute to working groups researching the use of R in Pharma such as the R consortium working groups
(CSRMLW and RTRS), R validation Hub, other SIGs (Data science/Visualization), PhUSE, Pharmaverse and Transcelerate and share this information with the wider PSI community.
Who we are
The AIMS SIG was formed in May 2016 and currently consists of the following team members:
Name | Company |
Martin Brown (Chair) | PPD, UK |
Lyn Taylor | Parexel, UK |
Andy Nicholls
| GSK, UK |
Christina Fillmore | GSK, UK |
Matthew Neilson | Phastar, UK |
Min-Hua Jen | Eli-Lilly, UK |
Michael Cartwright | Parexel, UK |
Chris Toffis
| Veristat, UK |
Mark Bynens | Janssen, Belgium |
Camilo Rojas Cifuentes | Janssen, Netherlands |
Jules Hernandez-Sanchez | Roche, UK |
Daniel Leibovitz
| Independent, Switzerland |
Kevin Kunzmann
| Boehringer-Ingelheim, Germany |
Marie-Laure Casadebaig | Incyte, Switzerland |
Irene Vassallo
| Incyte, Switzerland |
We are also closely linked to the R Validation Hub who are working on the collection of metrics for R packages and the production of guidance information on the use of R in the pharmaceutical industry. See the following for more information:
https://www.pharmar.org
How to get in touch
If you are interested in joining the AIMS SIG, then please contact Martin Brown: Martin.Brown@ppd.com
If you are interested in joining the R Validation Hub contact:
psi.aims.r.validation@gmail.com
R Validation Hub
AIMS was awarded funding from the R-Consortium in June 2018 to create of an online repository for R package validation in accordance with regulatory standards. The desire to use R in the pharmaceutical industry is evident due to it being a very
powerful object-orientated language, able to produce analyses and high quality graphics and being open source hence readily enabling bespoke extensions. It can be used for high performance computing and allows easy integration with other software.
It can also be used for complex analyses which is especially important when these analyses are not available in SAS. The AIMS SIG acted as a springboard for the R Validation Hub initiative which has now grown into it's own committee with involvement
of over 100 people representing 60 companies. For more information see: https://www.pharmar.org/ If you are interested in contributing to this project please contact:
psi.aims.r.validation@gmail.com.
R Training and Help
Substantial free training is available for R. Some of our favourite sources are listed below.